5-methyl-5,6,7,8-tetrahydro-1,6-naphthyridine → HCID 24810369, Verbindung
Reaktionsgleichung
[Cl:1][C:2]1[CH:3]=[N:4][C:5]2[N:6]([N:8]=[C:9]([C:11]([OH:13])=O)[CH:10]=2)[CH:7]=1.[CH3:14][CH:15]1[NH:24][CH2:23][CH2:22][C:21]2[N:20]=[CH:19][CH:18]=[CH:17][C:16]1=2>>[Cl:1][C:2]1[CH:3]=[N:4][C:5]2[N:6]([N:8]=[C:9]([C:11]([N:24]3[CH2:23][CH2:22][C:21]4[N:20]=[CH:19][CH:18]=[CH:17][C:16]=4[CH:15]3[CH3:14])=[O:13])[CH:10]=2)[CH:7]=1Komponenten
3
Versuchsvorschrift
In close analogy to the procedure described in Example 1, 6-chloro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid is reacted with 5-Methyl-5,6,7,8-tetrahydro-[1,6]naphthyridine to provide the title compound in moderate yield.
Quellen und Nachweise
- ORD-Eintrag
- ord-049945f01919414b8a7905224f14c91c
- Quelldatensatz
- uspto-grants-2011_07
- Patentnummer
- US07985753B2